HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas

References

[1]  Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363 2587–99.
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 21091279PubMed |

[2]  Montaner JSG. Treatment as prevention – a double hat-trick. Lancet 2011; 378 208–9.
| Treatment as prevention – a double hat-trick.Crossref | GoogleScholarGoogle Scholar |

[3]  Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365 493–505.
| Prevention of HIV-1 infection with early antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar | 21767103PubMed |

[4]  Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al Global epidemiology of HIV infection in men who have sex with men. Lancet 2012; 380 367–77.
| Global epidemiology of HIV infection in men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 22819660PubMed |

[5]  Centers for Disease Control and Prevention Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep 2011; 60 65–8.
| 21270743PubMed |

[6]  World Health Organization (WHO). Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach – 2010 revision. Geneva: WHO; 2010.

[7]  Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington DC: Department of Health and Human Services; 2013.

[8]  Kellerman SE, Hutchinson AB, Begley EB, Boyett BC, Clark HA, Sullivan P. Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004. J Acquir Immune Defic Syndr 2006; 43 376–7.
| Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004.Crossref | GoogleScholarGoogle Scholar | 17079995PubMed |

[9]  Voetsch AC, Heffelfinger JD, Begley EB, Jafa-Bhushan K, Sullivan PS. Knowledge and use of preexposure and postexposure prophylaxis among attendees of minority gay pride events, 2005 through 2006. J Acquir Immune Defic Syndr 2007; 46 378–80.
| Knowledge and use of preexposure and postexposure prophylaxis among attendees of minority gay pride events, 2005 through 2006.Crossref | GoogleScholarGoogle Scholar | 18090305PubMed |

[10]  Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, et al Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr 2008; 47 241–7.
| Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.Crossref | GoogleScholarGoogle Scholar | 18340656PubMed |

[11]  Barash EA, Golden M. Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS 2010; 24 689–91.
| Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic.Crossref | GoogleScholarGoogle Scholar | 20863247PubMed |

[12]  Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 2010; 54 548–55.
| Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 20512046PubMed |

[13]  Mansergh G, Koblin BA, Colfax GN, McKirnan DJ, Flores SA, Hudson SM. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr 2010; 55 e14–6.
| Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 20859085PubMed |

[14]  Mimiaga MJ, Case P, Johnson CV, Safren S, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 2009; 50 77–83.
| Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.Crossref | GoogleScholarGoogle Scholar | 19295337PubMed |

[15]  Koblin BA, Mansergh G, Frye V, Van Tieu H, Hoover DR, Bonner S, et al Condom-use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: Project MIX. J Acquir Immune Defic Syndr 2011; 58 319–27.
| Condom-use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: Project MIX.Crossref | GoogleScholarGoogle Scholar | 21765363PubMed |

[16]  Leonardi M, Lee E, Tan DHS. Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada. Int J STD AIDS 2011; 22 738–41.
| Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada.Crossref | GoogleScholarGoogle Scholar | 22174057PubMed |

[17]  Nodin N, Carballo-Diéguez A, Ventuneac AM, Balan IC, Remien R. Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care 2008; 20 106–15.
| Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback.Crossref | GoogleScholarGoogle Scholar | 18278621PubMed |

[18]  Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE. Attitudes towards new biomedical prevention technologies among a cohort of HIV-negative men in Sydney, Australia. HIV Med 2010; 11 282–8.
| Attitudes towards new biomedical prevention technologies among a cohort of HIV-negative men in Sydney, Australia.Crossref | GoogleScholarGoogle Scholar | 20015220PubMed |

[19]  Jackson T, Huang AL, Chen H, Gao X, Zhong XN, Zhang Y. Cognitive, psychosocial, and sociodemographic predictors of willingness to use HIV pre-exposure prophylaxis among Chinese men who have sex with men. AIDS Behav 2012; 16 1853–61.
| Cognitive, psychosocial, and sociodemographic predictors of willingness to use HIV pre-exposure prophylaxis among Chinese men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 22538373PubMed |

[20]  Galea JT, Kinsler JJ, Salazar X, Lee S, Giron M, Sayles JN, et al Galea JT, Kinsler JJ, Salazar X, Lee S, Giron M, Sayles JN, et al Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS 2011; 22 256–62.
| Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.Crossref | GoogleScholarGoogle Scholar |

[21]  Krakower DS, Mimiaga MJ, Rosenberger JG, Novak DS, Mitty JA, White JM, et al Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE 2012; 7 e33119
| Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site.Crossref | GoogleScholarGoogle Scholar |

[22]  Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS 2013; 27 248–54.
| From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.Crossref | GoogleScholarGoogle Scholar |

[23]  Galindo GR, Walker JJ, Hazelton P, Lane T, Steward WT, Morin SF, et al Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci 2012; 7

[24]  Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS 2012; 26 87–94.
| Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study.Crossref | GoogleScholarGoogle Scholar |

[25]  Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, et al Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS ONE 2012; 7 e50061
| Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study.Crossref | GoogleScholarGoogle Scholar |

[26]  Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE 2012; 7 e28238
| Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.Crossref | GoogleScholarGoogle Scholar |

[27]  Holt M, Murphy DA, Callander D, Ellard J, Rosengarten M, Kippax SC, et al Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect 2012; 88 258–63.
| Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men.Crossref | GoogleScholarGoogle Scholar |

[28]  Wheelock A, Eisingerich AB, Ananworanich J, Gomez GB, Hallett TB, Dybul MR, et al Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS ONE 2013; 8 e54288
| Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance.Crossref | GoogleScholarGoogle Scholar |

[29]  Zhou F, Gao L, Li SM, Li DL, Zhang LF, Fan WS, et al Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS ONE 2012; 7 e32329
| Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men.Crossref | GoogleScholarGoogle Scholar |

[30]  Holt M, Murphy D, Callander D, Ellard J, Rosengarten M, Kippax S, et al HIV-negative and HIV-positive gay men’s attitudes to medicines, HIV treatments and antiretroviral-based prevention. AIDS Behav 2013; 17 2156–61.
| HIV-negative and HIV-positive gay men’s attitudes to medicines, HIV treatments and antiretroviral-based prevention.Crossref | GoogleScholarGoogle Scholar |

[31]  Chen Y. Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009–2012) in an era of treatment as prevention. Curr HIV/AIDS Rep 2013; 10 79–88.
| Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009–2012) in an era of treatment as prevention.Crossref | GoogleScholarGoogle Scholar |

[32]  Elford J. Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. Curr Opin Infect Dis 2006; 19 26–32.
| Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar |

[33]  Van de Ven P, Crawford J, Kippax S, Knox S, Prestage G. A scale of optimism–scepticism in the context of HIV treatments. AIDS Care 2000; 12 171–6.
| A scale of optimism–scepticism in the context of HIV treatments.Crossref | GoogleScholarGoogle Scholar |

[34]  Kalichman SC, Eaton L, Cherry C. Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention. HIV Med 2010; 11 502–9.

[35]  Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitment antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des Médecins Suisses. 2008; 89 165–9.

[36]  Prestage G, Down IA, Bradley J, McCann PD, Brown G, Jin F, et al Is optimism enough? Gay men’s beliefs about HIV and their perspectives on risk and pleasure. Sex Transm Dis 2012; 39 167–72.
| Is optimism enough? Gay men’s beliefs about HIV and their perspectives on risk and pleasure.Crossref | GoogleScholarGoogle Scholar |

[37]  Sullivan PS, Carballo-Diéguez A, Coates T, Goodreau SM, McGowan I, Sanders EJ, et al Successes and challenges of HIV prevention in men who have sex with men. Lancet 2012; 380 388–99.
| Successes and challenges of HIV prevention in men who have sex with men.Crossref | GoogleScholarGoogle Scholar |

[38]  Landowitz RJ. How PrEP will roll out in practice (slowly, so far). Res Initiat Treat Action 2012; 17 34–40.

[39]  Muessig KE, Smith MK, Powers KA, Lo Y-R, Burns DN, Grulich AE, et al Does ART prevent HIV transmission among MSM? AIDS 2012; 26 2267–73.
| Does ART prevent HIV transmission among MSM?Crossref | GoogleScholarGoogle Scholar |